Medicus Pharma Ltd. Changes Auditor
Ticker: MDCXW · Form: 6-K · Filed: Dec 26, 2024 · CIK: 1997296
Sentiment: neutral
Topics: auditor-change, procedural
TL;DR
Medicus Pharma just swapped auditors, filing the paperwork on Dec 26th.
AI Summary
Medicus Pharma Ltd. filed a Form 6-K on December 26, 2024, reporting a change in its auditor. The filing includes a Notice of Change of Auditor, a letter from the former auditor, and a letter from the successor auditor. The company is incorporated in Canada and its principal executive office is located in Toronto.
Why It Matters
A change in auditor can sometimes signal underlying issues or a strategic shift within a company, warranting closer examination by investors.
Risk Assessment
Risk Level: low — This filing is procedural and does not contain information about financial performance or significant business events.
Key Players & Entities
- Medicus Pharma Ltd. (company) — Registrant
- December 26, 2024 (date) — Filing date
- Toronto, Ontario, Canada (location) — Principal executive office
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a change in the company's auditor.
When was this report filed with the SEC?
This report was filed with the SEC on December 26, 2024.
What exhibits are included with this filing?
The exhibits included are a Notice of Change of Auditor, a Letter of Former Auditor, and a Letter of Successor Auditor.
Where is Medicus Pharma Ltd.'s principal executive office located?
Medicus Pharma Ltd.'s principal executive office is located at Suite 3400, 100 King St W, Toronto, Ontario, Canada, M5X 1A4.
Does Medicus Pharma Ltd. file annual reports under Form 20-F or Form 40-F?
Medicus Pharma Ltd. indicated that it files annual reports under Form 20-F.
Filing Stats: 173 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2024-12-26 08:00:16
Filing Documents
- form6k.htm (6-K) — 7KB
- exhibit99-1.htm (EX-99.1) — 6KB
- exhibit99-2.htm (EX-99.2) — 4KB
- exhibit99-3.htm (EX-99.3) — 4KB
- exhibit99-2xu001.jpg (GRAPHIC) — 4KB
- exhibit99-2xu002.jpg (GRAPHIC) — 3KB
- exhibit99-2xu003.jpg (GRAPHIC) — 3KB
- exhibit99-2xu004.jpg (GRAPHIC) — 5KB
- exhibit99-3xu001.jpg (GRAPHIC) — 3KB
- exhibit99-3xu002.jpg (GRAPHIC) — 5KB
- 0001062993-24-021193.txt ( ) — 55KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicus Pharma Ltd. Date: December 26, 2024 By: /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer